Senzo

Senzo and Abingdon Health Enter Into Strategic Partnership Abingdon Health's CDMO service to support Senzo in leveraging its innovative, high-accuracy Amplified Lateral Flow (ALF) point-of-care diagnostics platform technology across multiple product opportunities. See more here

Senzo Secures Additional $1.9MM Equity Funding for Its PCR-Accurate Lateral Flow Test The funding, led by existing investors BioAdvance and Wellness Coaches, follows additional 3rd party studies by University College London and LateralDx, confirming that Senzo's Amplified Lateral Flow (ALF) platform returned greater than 98% accuracy against PCR, including in…

Senzo Receives Funding from the Biomedical Advanced Research and Development Authority (BARDA) to Advance Its PCR-Accurate Lateral Flow COVID-19 Test See more here

Senzo lands $2M investment to advance at-home tests for infectious diseases See more here